Loading…

BD plans to invest over $30 million in 2025 to expand manufacturing capacity for IV lines at its plant in Utah, following a 2024 investment of over $2 million that increased IV catheter output by more than 40 million units annually.
“Domestic manufacturing is crucial for ensuring a resilient supply of essential health care devices.”respiratory-therapy.com
Summarized from public sources; check the original articles before acting on it.